94
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Glial Fibrillary Acidic Protein Levels in Post-Stroke Depression: A Prospective Ischemic Stroke Cohort

, , , &
Pages 2171-2178 | Received 11 Aug 2023, Accepted 12 Oct 2023, Published online: 18 Oct 2023

References

  • Johnson CO, Nguyen M, Roth GA. Collaborators. GS. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):439–458. doi:10.1016/S1474-4422(19)30034-1
  • Robinson R, Jorge R. Post-stroke depression: a review. Am J Psychiatry. 2016;173(3):221‐31. doi:10.1176/appi.ajp.2015.15030363
  • Towfighi A, Ovbiagele B, El Husseini N, et al. Poststroke depression: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2017;48(2):e30–e43. doi:10.1161/STR.0000000000000113
  • Schöttke H, Giabbiconi C. Post-stroke depression and post-stroke anxiety: prevalence and predictors. Int Psychogeriatr. 2015;27(11):1805–1812. doi:10.1017/S1041610215000988
  • Parikh R, Robinson R, Lipsey J, Starkstein S, Fedoroff J, Price T. The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up. Arch Neurol. 1990;47(7):785–789. doi:10.1001/archneur.1990.00530070083014
  • Chemerinski E, Robinson R, Kosier J. Improved recovery in activities of daily living associated with remission of poststroke depression. Stroke. 2001;32(1):113–117. doi:10.1161/01.STR.32.1.113
  • Cai W, Mueller C, Li Y, Shen W, Stewart R. Post stroke depression and risk of stroke recurrence and mortality: a systematic review and meta-analysis. Ageing Res Rev. 2019;50:102–109. doi:10.1016/j.arr.2019.01.013
  • Yang Z, Wang K. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 2015;38(6):364–374. doi:10.1016/j.tins.2015.04.003
  • Middeldorp J, Hol E. GFAP in health and disease. Prog Neurobiol. 2011;93(3):421–443. doi:10.1016/j.pneurobio.2011.01.005
  • Gomi H, Yokoyama T, Itohara S. Role of GFAP in morphological retention and distribution of reactive astrocytes induced by scrapie encephalopathy in mice. Brain Res. 2010;1312:156–167. doi:10.1016/j.brainres.2009.11.025
  • Pekny M, Stanness K, Eliasson C, Betsholtz C, Janigro D. Impaired induction of blood-brain barrier properties in aortic endothelial cells by astrocytes from GFAP-deficient mice. Glia. 1998;22(4):390–400. doi:10.1002/(SICI)1098-1136(199804)22:4<390::AID-GLIA8>3.0.CO;2-7
  • Wunderlich M, Wallesch C, Goertler M. Release of glial fibrillary acidic protein is related to the neurovascular status in acute ischemic stroke. Eur J Neurol. 2006;13(10):1118–1123. doi:10.1111/j.1468-1331.2006.01435.x
  • Katsanos A, Makris K, Stefani D, et al. Plasma glial fibrillary acidic protein in the differential diagnosis of intracerebral hemorrhage. Stroke. 2017;48(9):2586–2588. doi:10.1161/STROKEAHA.117.018409
  • Amalia L. Glial Fibrillary Acidic Protein (GFAP): neuroinflammation biomarker in acute ischemic stroke. J Inflamm Res. 2021;14:7501–7506. doi:10.2147/JIR.S342097
  • Elahi FM, Casaletto KB, La Joie R, et al. Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer’s disease. Alzheimers Dement. 2020;16(4):681–695. doi:10.1016/j.jalz.2019.09.004
  • Herrmann M, Vos P, Wunderlich M, Lamers K. Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke. 2000;31(11):2670–2677. doi:10.1161/01.STR.31.11.2670
  • Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO task force on stroke and other cerebrovascular disorders. Stroke. 1989;20(10):1407–1431. doi:10.1161/01.STR.20.10.1407
  • Brott T, Adams HJ, Olinger C, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864–870. doi:10.1161/01.STR.20.7.864
  • Adams HJ, Bendixen B, Kappelle L, Biller J, Love B, Gordon D. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41. doi:10.1161/01.STR.24.1.35
  • Zimmerman M, Martinez J, Young D, Chelminski I, Dalrymple K. Severity classification on the Hamilton depression rating scale. J Affect Disord. 2013;150(2):384–388. doi:10.1016/j.jad.2013.04.028
  • Wang G, Zhou Y, Bu X, et al. Antiphospholipid antibodies predict post-stroke depression after acute ischemic stroke. J Affect Disord. 2019;257:160–165. doi:10.1016/j.jad.2019.07.013
  • Chen Y, Qu J, Xiao W, et al. Intracranial atherosclerosis and poststroke depression in Chinese patients with ischemic stroke. J Stroke Cerebrovasc Dis. 2016;25(4):998–1004. doi:10.1016/j.jstrokecerebrovasdis.2015.12.038
  • Zhu Z, Guo D, Shi M, et al. Effect of immediate blood pressure reduction on post-stroke depression in ischemic stroke patients: a substudy of CATIS trial. J Affect Disord. 2022;300:195–202. doi:10.1016/j.jad.2021.12.120
  • Medeiros G, Roy D, Kontos N, Beach S. Post-stroke depression: a 2020 updated review. Gen Hosp Psychiatry. 2020;66:70–80. doi:10.1016/j.genhosppsych.2020.06.011
  • De Ryck A, Brouns R, Geurden M, Elseviers M, De Deyn PP, Engelborghs S. Risk factors for poststroke depression: identification of inconsistencies based on a systematic review. J Geriatr Psychiatry Neurol. 2014;27(3):147–158. doi:10.1177/0891988714527514
  • Zhang Y, Cheng L, Chen Y, Yang G, Liu J, Zeng L. Clinical predictor and circulating microRNA profile expression in patients with early onset post-stroke depression. J Affect Disord. 2016;193:51–58. doi:10.1016/j.jad.2015.12.061
  • Chi C, Huang Y, Ye S, et al. Interleukin-10 level is associated with post-stroke depression in acute ischaemic stroke patients. J Affect Disord. 2021;293:254–260. doi:10.1016/j.jad.2021.06.037
  • Rudilosso S, Rodríguez-Vázquez A, Urra X, Arboix A. The potential impact of neuroimaging and translational research on the clinical management of lacunar stroke. Int J Mol Sci. 2022;23(3):1497. doi:10.3390/ijms23031497
  • Garwood C, Ratcliffe L, Simpson J, Heath P, Ince P, Wharton S. Review: astrocytes in Alzheimer’s disease and other age-associated dementias: a supporting player with a central role. Neuropathol Appl Neurobiol. 2017;43(3):281–298. doi:10.1111/nan.12338
  • Oppenheim R, Houenou L, Parsadanian A, Prevette D, Snider W, Shen L. Glial cell line-derived neurotrophic factor and developing mammalian motoneurons: regulation of programmed cell death among motoneuron subtypes. J Neurosci. 2000;20(13):5001–5011. doi:10.1523/JNEUROSCI.20-13-05001.2000
  • Struzyńska L. A glutamatergic component of lead toxicity in adult brain: the role of astrocytic glutamate transporters. Neurochem Int. 2009;55(1–3):151–156. doi:10.1016/j.neuint.2009.01.025
  • Blanco-Rojas L, Arboix A, Canovas D, Grau-Olivares M, Oliva Morera JC, Parra O. Cognitive profile in patients with a first-ever lacunar infarct with and without silent lacunes: a comparative study. BMC Neurol. 2013;13(1):203. doi:10.1186/1471-2377-13-203